Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.16) per share. This is a 20 percent increase over losses of $(0.20) per share from the same period last year. The company reported $35.747 million in sales this quarter. This is a 5.65 percent decrease over sales of $37.886 million the same period last year.